# Effect of RIC on 2,3-BPG in Erythrocyte (RIC-BPG)

> **NCT04192578** · NA · UNKNOWN · sponsor: **Capital Medical University** · enrollment: 40 (estimated)

## Conditions studied

- 2,3-Bisphosphoglycerate

## Interventions

- **DEVICE:** remote ischemic conditioning

## Key facts

- **NCT ID:** NCT04192578
- **Lead sponsor:** Capital Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-15
- **Primary completion:** 2021-03-15
- **Final completion:** 2021-03-15
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2020-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04192578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04192578, "Effect of RIC on 2,3-BPG in Erythrocyte (RIC-BPG)". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04192578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*